The rhizome of Dryopteris crassirhizoma (Aspiadaceae) has been used as a tapeworm remedy, a cold remedy, and a therapeutic agent of viral diseases in traditional Chinese medicine.
3) From this plant, phloroglucinols have been reported as anti-bacterial and anti-oxidative agents, 4, 5) and our group has reported four kaempferol acetylrhamnosides as HIV-1 reverse transcriptase inhibitors. 6) In the screening of Mongolian herbal medicines for their inhibitory activity against HIV-1 protease, an MeOH extract of the Rhizome of D. crassirhizoma showed potent activity with 89.2% inhibition at 200 mg/ml. 7) However, compounds responsible for this HIV-1 protease inhibitory activity have not yet been reported. Therefore, we intended to isolate HIV-1 protease inhibitors from this plant. This paper reports the isolation and structure determination, and inhibitory activity of compounds from D. crassirhizoma against HIV-1 protease in vitro.
The CHCl 3 -, EtOAc-, BuOH-and H 2 O-soluble fractions obtained from the MeOH extract showed potent activities with 82.5, 73.3, 78.3 and 81.3% at 100 mg/ml, respectively.
Eighteen compounds (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) were isolated from each fraction (eleven, seven, and two) compounds from the CHCl 3 -, EtOAc-, and BuOH-soluble fractions, respectively) using repeatedly normal and reversed phase silica gel column, Sephadex LH-20, Diaion HP-20, Sep-pak, and preparative HPLC. By comparing their spectral data with those of published values (Fig. 1) , the isolated compounds 3-18 were determined to be dimethylflavanones [desmethoxymatteucinol (3), matteucinol (4), and methoxymatteucin (5)], [8] [9] [10] 
Two New Triterpenes from the Rhizome of Dryopteris crassirhizoma, and Inhibitory Activities of Its Constituents on Human Immunodeficiency
Virus-1 Protease 7, 11) 3,4-dihydroxybenzaldehyde (13), 16b,17-dihydroxykauran-18-oic acid (14) , 12, 13) ursolic acid (15) , stearic acid (16), b-sitosterol (17), and b-sitosterol glucoside (18) . Of the known compounds, 3-8 and 13-15 were isolated for the first time from this plant family. Compounds 1 and 2 were new, and their structures were determined as follows:
Compound 1 was obtained as a white amorphous powder. The molecular formula C 30 H 48 O 3 was assigned by high-resolution electron impact mass spectrum (HR-EI-MS). The 14)
The 13 C-NMR spectrum was indicative of a triterpene of 21bH-hop-22(29)-ene series by comparing the reported values of hopane and isohopane (Table 1) . [14] [15] [16] [17] Specifically, the signals at d 46. C COSY, and heteronuclear multiple bonding correlation (HMBC) spectral data. Therefore, the chemical structure of compound 1 was elucidated as 2b-hydroxy-21bH-hop-22(29)-ene-24-oic acid.
Compound 2 was also purified as a white amorphous powder. The HR-MS spectrum of compound 2 also showed a molecular ion at m/z 456.3611, which was in agreement with the molecular formula C 30 H 48 O 3 . Spectral data of 2 were quite similar to those of 1, suggesting that 2 was the same planar structure of 1. The C, D, and E rings of these two compounds were identical by comparison of 1D and 2D NMR spectra (Table 1 (Table 2) . Dryopteric acid A (1) bearing a carboxylic acid group at 24 position (IC 50 , 26.5 mM) showed more potent inhibitory activity than dryopteric acid B (2) bearing a carboxylic acid group at 23 position (IC 50 , 44.5 mM). Interestingly, the activities of 1 and 2 were abruptly increased by a factor of 15 and 4 times by acetylating the 2b hydroxyl group, respectively (1a, IC 50 , 1.7 mM, 2a, IC 50 , 10.8 mM). In the results, 2b-acetoxy-21bH-hop-22(29)-ene-24-oic acid (1a) showed the most potent activity (IC 50 , 1.7 mM) of all the compounds examined. These results proposed that the carboxylic group at the 24 position, and the acetyl group at the 2 position could play key roles in the inhibition of HIV-1 protease in these triterpene acids of the hopane series. In addition, 6,8-dimethylflavanones (3-5) moderately inhibited enzyme activity with IC 50 values of 105.9 (3), 64.3 (4), and 106.9 (5) mM, and kaempferol rhamnosides (6, 9, 12) exhibited weak inhibitory activities (IC 50 , 146.6, 88.0, 100.1 mM) against HIV-1 protease. 3,4-Dihydoxybenzaldehyde (13) , and ursolic acid (15) also inhibited HIV-1 protease with IC 50 values of 27.5 and 8.9 mM.
Experimental
General Optical rotations were measured with a Jasco DIP-1000 automatic polarimeter (Jasco Co., Tokyo, Japan). IR spectra were measured with a Jasco FT/IR-230 infrared spectrometer. UV spectra were measured with a UV-2200 UV-VIS recording spectrometer (Shimadzu Co., Kyoto, Japan). NMR spectra were taken on either a Varian Unity 500 ( 1 H, 500 MHz; 13 (5) 100.9 Kaempferol 7-O-a-L-rhamnopyranoside (6) 146.6
Sutchuenoside A (9) 88.0 Crassirhizomoside A (10) Ͼ300 Crassirhizomoside B (11) Ͼ300 Crassirhizomoside C (12) 100.1 3,4-Dihydroxybenzaldehyde (13) 27.5 16b,17-Dihydroxykauran-18-oic acid (14) Ͼ300 Ursolic acid (15) 8.9 Stearic acid (16)
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a) The IC 50 value was defined as a concentration of compounds needed to reduce 50% of a p-NO 2 -Phe-bearing hydrolysate peak relative to control. The data are mean values of three experiments performed in triplicate. b) Acetyl-pepstatin as positive control. 30), 1.62 (3H, s, CH 3 -24), 1.18 (3H, s, CH 3 -25), 0.98 (3H, s, CH 3 -26) , 0.87 (3H, s, CH 3 -27), 0.68 (3H, s, CH 3 -28).
HIV-1 Protease Activity Assay 18) The inhibitory activity of test samples against HIV-1 protease was determined by an HPLC method using synthetic peptide [His-Lys-Ala-Arg-Val-Leu-(pNO 2 -Phe)-Glu-Ala-Nle-Ser-NH 2 ] as a substrate, which was purchased from Bachem Feinchemikalien AG (Bubendorf, Switzerland). The fused recombinant HIV-1 PR was obtained as previously reported. A reaction mixture (25 ml) containing a substrate (2.5 mg), 2.5 ml of a test compound dissolved in DMSO, and 2.5 ml of recombinant HIV-1 PR (0.175 mg protein), in 50 mM acetate buffer (pH 5.0) was incubated at 37°C for 15 min. The reaction was stopped by the addition of 2.5 ml of 10% trifluoroacetic acid. The hydrolysate and remaining substrate were quantitatively analyzed by HPLC. The HPLC system was composed of an LC9A liquid chromatograph, an SPD-6A UV spectrophotometric detector, an SLC-6B autoinjector and an integrator C-R6A Chromatopac (Shimadzu Co., Kyoto, Japan). Five microliters of the reaction mixture was injected into a reversed phased ODS column (4.6ϫ150 mm, YMC) and eluted with a gradient of acetonitrile (15-40%) in 0.1% trifluoroacetic acid at a flow rate of 1.0 ml/min. The elution profile was monitored at 280 nm. The substrate and p-NO 2 -Phe-bearing hydrolysate were eluted at 11.9 and 7.3 min, respectively. Acetyl-pepstatin, which was widely used as positive control, showed an IC 50 of 0.09 mM under these conditions.
